Jump to content

Claisen: Difference between revisions

From WikiGenius
Creating a page for Claisen
 
Nrvig (talk | contribs)
Added Claisen page to wikigenius
 
Line 12: Line 12:
| area_served    = United States
| area_served    = United States
| key_people      = Rishab Jain (CEO); Aditya Jain (CMO); Akash Pai (CPO)
| key_people      = Rishab Jain (CEO); Aditya Jain (CMO); Akash Pai (CPO)
| website        = claisen.com
}}
'''Claisen''' (legally '''Claisen Inc.''') is an American telehealth company focused on gastrointestinal (GI) self-care. The company offers direct-to-consumer, subscription kits for symptoms such as heartburn, bloating, and gas that are personalized via an online onboarding questionnaire. Claisen is headquartered in Boston, Massachusetts and was founded in 2025 by Rishab Jain, Aditya Jain, and Akash Pai.
== Founding and growth ==
Claisen was founded in 2025 by brothers Rishab Jain and Aditya Jain, together with Akash Pai, to deliver personalized, data-guided GI care through a direct-to-consumer model.
== Products and services ==
Customers complete an AI-assisted intake quiz, after which Claisen ships monthly kits that may include over-the-counter medications, nutraceuticals, and behavior guidance tailored to reported symptoms. The company positions the offering as a unified alternative to fragmented GI self-care for common conditions such as gastroesophageal reflux disease (GERD) and functional bloating.
== Operations and compliance ==
Claisen’s published terms state that the platform does not provide medical diagnosis or treatment and that its offerings are limited to non-prescription, OTC products. The company’s privacy policy describes data-security practices and HIPAA-aligned controls, including use of business associate agreements with certain partners.
== References ==
* [Reference 1 placeholder]
* [Reference 2 placeholder]
* [Reference 3 placeholder]
== External links ==
* Official website: claisen.com 
* Business data for Claisen Inc.:
** F6S 
** Crunchbase 
** Tracxn (subscription required) 
** PitchBook (subscription required)
[[Category:Telemedicine]]
[[Category:Health care companies of the United States]]
[[Category:Companies based in Boston]]
[[Category:American companies established in 2025]]
[[Category:Health care companies established in 2025]]

Latest revision as of 05:36, 31 August 2025


Claisen (legally Claisen Inc.) is an American telehealth company focused on gastrointestinal (GI) self-care. The company offers direct-to-consumer, subscription kits for symptoms such as heartburn, bloating, and gas that are personalized via an online onboarding questionnaire. Claisen is headquartered in Boston, Massachusetts and was founded in 2025 by Rishab Jain, Aditya Jain, and Akash Pai.

Founding and growth

Claisen was founded in 2025 by brothers Rishab Jain and Aditya Jain, together with Akash Pai, to deliver personalized, data-guided GI care through a direct-to-consumer model.

Products and services

Customers complete an AI-assisted intake quiz, after which Claisen ships monthly kits that may include over-the-counter medications, nutraceuticals, and behavior guidance tailored to reported symptoms. The company positions the offering as a unified alternative to fragmented GI self-care for common conditions such as gastroesophageal reflux disease (GERD) and functional bloating.

Operations and compliance

Claisen’s published terms state that the platform does not provide medical diagnosis or treatment and that its offerings are limited to non-prescription, OTC products. The company’s privacy policy describes data-security practices and HIPAA-aligned controls, including use of business associate agreements with certain partners.

References

  • [Reference 1 placeholder]
  • [Reference 2 placeholder]
  • [Reference 3 placeholder]

External links

  • Official website: claisen.com
  • Business data for Claisen Inc.:
    • F6S
    • Crunchbase
    • Tracxn (subscription required)
    • PitchBook (subscription required)
Cookies help us deliver our services. By using our services, you agree to our use of cookies.